U.S. Court in DC Says HHS Can Require Preapproval of Drug Makers’ 340B Rebate Models
- May 23, 2025
The Department of Health and Human Services (HHS) did not act contrary to the law by requiring drug manufacturers to obtain the agency’s approval before shifting to a rebate model for providing discounts under the 340B program, the U.S. District Court for the District of Columbia held May 15.
ARTICLE TAGS
You must be logged in to access this content.